WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011014332) SELECTIVE ALPHA 2B/2C AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/014332    International Application No.:    PCT/US2010/040788
Publication Date: 03.02.2011 International Filing Date: 01.07.2010
IPC:
C07D 263/28 (2006.01), C07D 277/18 (2006.01), A61K 31/426 (2006.01), A61K 31/421 (2006.01), A61P 27/00 (2006.01)
Applicants: ALLERGAN, INC. [US/US]; 2525 Dupont Drive T2-7H Irvine, California 92612 (US) (For All Designated States Except US).
NGUYEN, Phong X. [US/US]; (US) (For US Only).
CHOW, Ken [US/US]; (US) (For US Only).
HEIDELBAUGH, Todd M. [US/US]; (US) (For US Only).
GOMEZ, Dario G. [US/US]; (US) (For US Only).
FANG, Wenkui K. [US/US]; (US) (For US Only).
SINHA, Santosh C. [IN/US]; (US) (For US Only).
GARST, Michael E. [US/US]; (US) (For US Only).
GIL, Daniel W. [US/US]; (US) (For US Only)
Inventors: NGUYEN, Phong X.; (US).
CHOW, Ken; (US).
HEIDELBAUGH, Todd M.; (US).
GOMEZ, Dario G.; (US).
FANG, Wenkui K.; (US).
SINHA, Santosh C.; (US).
GARST, Michael E.; (US).
GIL, Daniel W.; (US)
Agent: WURST, John; Allergan, Inc. 2525 Dupont Drive Irvine, California 92612 (US)
Priority Data:
61/229,910 30.07.2009 US
Title (EN) SELECTIVE ALPHA 2B/2C AGONISTS
(FR) AGONISTES SÉLECTIFS DES RÉCEPTEURS ALPHA 2B/2C
Abstract: front page image
(EN)Described herein are compounds useful as agonists of alpha 2B/2C receptors. Pharmaceutical compositions including the presently described compounds and methods of treatment of diseases and conditions with the presently described compounds also are disclosed.
(FR)La présente invention concerne des composés utiles en tant qu'agonistes des récepteurs alpha 2B/2C. L'invention concerne des compositions pharmaceutiques contenant les composés présentement décrits et des méthodes de traitement de maladies et d'affections avec les composés présentement décrits.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)